Malignant News and Research

RSS
Cholangiocarcinoma: New Organ-On-Chip Aims at Accelerating Research and Personalized Medicine

Cholangiocarcinoma: New Organ-On-Chip Aims at Accelerating Research and Personalized Medicine

USC Scientists Discover Protein Key to 3D Genome Control and Gene Silencing

USC Scientists Discover Protein Key to 3D Genome Control and Gene Silencing

Gene Splicing Affects CD20 Expression and Response to Cancer Immunotherapy

Gene Splicing Affects CD20 Expression and Response to Cancer Immunotherapy

Epigenetic Changes Drive Cancer Development

Epigenetic Changes Drive Cancer Development

New Way to Visualize Tumors During Surgery

New Way to Visualize Tumors During Surgery

Researchers Develop Bio-Inspired Drug to Boost Efficacy of Cancer Immunotherapy

Researchers Develop Bio-Inspired Drug to Boost Efficacy of Cancer Immunotherapy

Ribo-seq Optimization to Gain Insights into Protein Production

Ribo-seq Optimization to Gain Insights into Protein Production

Pre-Targeted Radioimmunotherapy System Cures Fatal Ovarian Cancer in Preclinical Study

Pre-Targeted Radioimmunotherapy System Cures Fatal Ovarian Cancer in Preclinical Study

Iron-Targeting Compounds Hamper Proliferation of Cancer Cells

Iron-Targeting Compounds Hamper Proliferation of Cancer Cells

Detection of Mutations in Children with Brain Tumors

Detection of Mutations in Children with Brain Tumors

Determining a Network of Cellular Programs Controlling Human Cancers

Determining a Network of Cellular Programs Controlling Human Cancers

New Proof-of-Concept Model for Delivering Gene Editing Tools to Treat Blood Disorders

New Proof-of-Concept Model for Delivering Gene Editing Tools to Treat Blood Disorders

3D Bioprinting Technology Developed to Eliminate Cancer Cells

3D Bioprinting Technology Developed to Eliminate Cancer Cells

cBAF Protein Complex Controls the Fate of T Cells

cBAF Protein Complex Controls the Fate of T Cells

Virus Plays Important Role in Treating Glioblastoma

Virus Plays Important Role in Treating Glioblastoma

Liver Cancers With Key Epigenetic Alteration Tend to Have a Poor Clinical Prognosis

Liver Cancers With Key Epigenetic Alteration Tend to Have a Poor Clinical Prognosis

Study Implicates RNA Molecules as New Players in Esophageal Cancer

Study Implicates RNA Molecules as New Players in Esophageal Cancer

Understanding How Cell-to-Cell Communication Networks Drive Pancreatic Cancer Development

Understanding How Cell-to-Cell Communication Networks Drive Pancreatic Cancer Development

Patient-Derived Organoids can Help Identify Effective Personalized Cancer Therapies

Patient-Derived Organoids can Help Identify Effective Personalized Cancer Therapies

Multi-Angled Approach of Identifying Dual-Purpose Therapeutic Targets Implicated in Aging, Glioblastoma

Multi-Angled Approach of Identifying Dual-Purpose Therapeutic Targets Implicated in Aging, Glioblastoma

Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.